170 related articles for article (PubMed ID: 33001974)
1. Prognostic factors of recovery with medication in patients with taste disorders.
Nomura Y; Toi T; Ikeda M; Ikeda A; Tanaka M; Oshima T
PLoS One; 2020; 15(10):e0237270. PubMed ID: 33001974
[TBL] [Abstract][Full Text] [Related]
2. [Involvement of zinc in taste disturbance occurring during treatment for malignant tumor in the chest and the effects of polaprezinc oral disintegrating tablets (a retrospective study)].
Nakata Y; Hirashima T; Kondou Y; Tokuoka Y; Imazato H; Iwata K; Oomori Y; Yamato A; Shimizu S; Nagao S; Matsui K; Abe N
Gan To Kagaku Ryoho; 2008 Jun; 35(6):955-9. PubMed ID: 18633224
[TBL] [Abstract][Full Text] [Related]
3. [Time course of changes in gustatory function test results and subjective symptoms, and predictive factors for response in patients with taste disorder receiving 24-week zinc replacement treatment].
Sakagami M; Kurono Y; Inokuchi A; Takeda N; Aiba T; Nin T; Ikeda M
Nihon Jibiinkoka Gakkai Kaiho; 2014 Aug; 117(8):1093-101. PubMed ID: 25255648
[TBL] [Abstract][Full Text] [Related]
4. Effects of polaprezinc on morphological change of the tongue in zinc-deficient rats.
Kinomoto T; Sawada M; Ohnishi Y; Yamaguchi T; Tsuge S; Ogawa S; Washizuka M; Minaguchi J; Mera Y; Takehana K
J Oral Pathol Med; 2010 Sep; 39(8):617-23. PubMed ID: 21054547
[TBL] [Abstract][Full Text] [Related]
5. A Review of Zinc-L-Carnosine and Its Positive Effects on Oral Mucositis, Taste Disorders, and Gastrointestinal Disorders.
Hewlings S; Kalman D
Nutrients; 2020 Feb; 12(3):. PubMed ID: 32121367
[TBL] [Abstract][Full Text] [Related]
6. A zinc-containing compound, Polaprezinc, is effective for patients with taste disorders: randomized, double-blind, placebo-controlled, multi-center study.
Sakagami M; Ikeda M; Tomita H; Ikui A; Aiba T; Takeda N; Inokuchi A; Kurono Y; Nakashima M; Shibasaki Y; Yotsuya O
Acta Otolaryngol; 2009 Oct; 129(10):1115-20. PubMed ID: 19037756
[TBL] [Abstract][Full Text] [Related]
7. [Development of polaprezinc research].
Takei M
Yakugaku Zasshi; 2012; 132(3):271-7. PubMed ID: 22382829
[TBL] [Abstract][Full Text] [Related]
8. Effect of polaprezinc on taste disorders in zinc-deficient rats.
Hamano H; Yoshinaga K; Eta R; Emori Y; Kawasaki D; Iino Y; Sawada M; Kuroda H; Takei M
Biofactors; 2006; 28(3-4):185-93. PubMed ID: 17473379
[TBL] [Abstract][Full Text] [Related]
9. [The Effectiveness of Polaprezinc Preparation for Taste Alteration in Cancer Chemotherapy].
Mizukami Y; Sato J; Nihei S; Kashiwaba M; Kudo K; Okuyama H; Tamura K
Gan To Kagaku Ryoho; 2016 Aug; 43(8):979-83. PubMed ID: 27539040
[TBL] [Abstract][Full Text] [Related]
10. Taste disorders: a survey of the examination methods and treatments used in Japan.
Ikeda M; Aiba T; Ikui A; Inokuchi A; Kurono Y; Sakagami M; Takeda N; Tomita H
Acta Otolaryngol; 2005 Nov; 125(11):1203-10. PubMed ID: 16353402
[TBL] [Abstract][Full Text] [Related]
11. Oral treatment of pressure ulcers with polaprezinc (zinc L-carnosine complex): 8-week open-label trial.
Sakae K; Yanagisawa H
Biol Trace Elem Res; 2014 Jun; 158(3):280-8. PubMed ID: 24691900
[TBL] [Abstract][Full Text] [Related]
12. Effects of zinc supplementation on serum zinc concentration and ratio of apo/holo-activities of angiotensin converting enzyme in patients with taste impairment.
Takaoka T; Sarukura N; Ueda C; Kitamura Y; Kalubi B; Toda N; Abe K; Yamamoto S; Takeda N
Auris Nasus Larynx; 2010 Apr; 37(2):190-4. PubMed ID: 19716667
[TBL] [Abstract][Full Text] [Related]
13. Taste and smell disturbances in cancer patients: a scoping review of available treatments.
Sevryugin O; Kasvis P; Vigano M; Vigano A
Support Care Cancer; 2021 Jan; 29(1):49-66. PubMed ID: 32734392
[TBL] [Abstract][Full Text] [Related]
14. Oral zinc therapy for zinc deficiency-related telogen effluvium.
Karashima T; Tsuruta D; Hamada T; Ono F; Ishii N; Abe T; Ohyama B; Nakama T; Dainichi T; Hashimoto T
Dermatol Ther; 2012; 25(2):210-3. PubMed ID: 22741940
[TBL] [Abstract][Full Text] [Related]
15. [Orally administered polaprezinc significantly improves taste disorders in ovarian cancer patient undergoing chemotherapy].
Nishijima S; Yanase T; Hata Y; Tamura R; Tsuneki I; Tamura M; Kurabayashi T
Gan To Kagaku Ryoho; 2011 Apr; 38(4):689-92. PubMed ID: 21499007
[TBL] [Abstract][Full Text] [Related]
16. Improvement of Dysgeusia by Polaprezinc, a Zinc-L-carnosine, in Outpatients Receiving Cancer Chemotherapy.
Fujii H; Hirose C; Ishihara M; Iihara H; Imai H; Tanaka Y; Matsuhashi N; Takahashi T; Yamaguchi K; Yoshida K; Suzuki A
Anticancer Res; 2018 Nov; 38(11):6367-6373. PubMed ID: 30396959
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of zinc-carnosine chelate compound, Polaprezinc, enemas in patients with ulcerative colitis.
Itagaki M; Saruta M; Saijo H; Mitobe J; Arihiro S; Matsuoka M; Kato T; Ikegami M; Tajiri H
Scand J Gastroenterol; 2014 Feb; 49(2):164-72. PubMed ID: 24286534
[TBL] [Abstract][Full Text] [Related]
18. [The effect of zinc agent in 219 patients with zinc deficiency-inductive/ idiopathic taste disorder: a placebo controlled randomized study].
Ikeda M; Kurono Y; Inokuchi A; Takeda N; Aiba T; Nomura Y; Sakagami M
Nihon Jibiinkoka Gakkai Kaiho; 2013 Jan; 116(1):17-26. PubMed ID: 23484369
[TBL] [Abstract][Full Text] [Related]
19. The trace metal zinc and taste.
Catalanotto FA
Am J Clin Nutr; 1978 Jun; 31(6):1098-103. PubMed ID: 352129
[No Abstract] [Full Text] [Related]
20. Important role of umami taste sensitivity in oral and overall health.
Sasano T; Satoh-Kuriwada S; Shoji N; Iikubo M; Kawai M; Uneyama H; Sakamoto M
Curr Pharm Des; 2014; 20(16):2750-4. PubMed ID: 23886385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
